Abstract:Background Heart failure (HF) is a syndrome due to cardiac insufficiency, manifested by excessive volume overload, increased sympathetic activity, and circulatory redistribution [1]. Heart failure with preserved ejection fraction (HFpEF) accounts for approximately 40%-50% of the total HF events, and its development is often accompanied by various complications, including hypertension, obesity, and metabolic syndrome. Biomarker associations in heart failure with reduced ejection fraction were mostly cardiac stretch based, while many biomarkers of HFpEF are also associated with inflammation [2]. To date, treatments that effectively improve the clinical prognosis of HFpEF are relatively limited, thus HFpEF remains one of the challenges that needs to be further explored. A full understanding of the molecular mechanisms of HFpEF is essential to improve the early diagnosis, treatment and prognosis of these patients. Purpose The study aims to explore key circulating miRNAs and related molecular pathways in HFpEF patients through bioinformatics analysis and machine learning, and to further validate them using a double-hit HFpEF mouse model. Methods We downloaded HF datasets including circulating miRNA expression profiles from the GEO database. LASSO regression, SVM-RFE, Random Forest and XGboost algorithm were conducted to identify key miRNAs for diagnostic model construction. We used R software, GO, KEGG and Cytoscape to better understand the functions of key miRNA targets. Besides, the mRNA-miRNA interaction networks were predicted by starbase. We also constructed a HFpEF mouse model subjected to high fat diet and L-NAME (0.5 g/L) in drinking water to discover the correlation between the screened circulating miRNA and HFpEF. Results After differential expression analysis of the combined HFpEF dataset, we identified 37 differentially circulating miRNAs, of which 15 were down-regulated and 22 were up-regulated. Subsequently, we screened by machine learning and identified 4 key miRNAs that may be involved in the progression of HFpEF, including hsa-miR-645, hsa-miR-296-5p, hsa-miR-199b-5p, and hsa-miR-509-3-5p. We validated these miRNAs based on their expression, and the ROC plots suggest that these miRNAs may have diagnostic capability in HFpEF. The results of GO and KEGG enrichment analyses showed that the target genes of the differentiated miRNAs were mainly enriched in the MAPK signaling pathway, mTOR signaling pathway, protein processing in endoplasmic reticulum, hippo signaling pathway, cell cycle, Foxo signaling pathway, hypertrophic cardiomyopathy, dilated cardiomyopathy, and circadian rhythm. The mRNA-miRNA interaction networks suggested that TMEM135 was regulated by both has-miR-199b-5p and hsa-miR-296-5p. The RT-PCR results also suggested that miR-199b-5p was upregulated in the HFpEF mice. Conclusion We validated 4 circulating miRNAs with strong correlation to HFpEF, which provide a more reliable basis for pre-symptomatic diagnosis.

Circulating miR-665 and miR-30 c-1-3 p , the candidate markers of congestive heart failure with qi-deficiency-blood-stasis syndrome

Expression of Mir-126 and Mir-508-5p in Endothelial Progenitor Cells is Associated with the Prognosis of Chronic Heart Failure Patients

Analysis of Microrna Expression Profiles Induced by Yiqifumai Injection in Rats with Chronic Heart Failure

Circulating miR-30d Predicts Survival in Patients with Acute Heart Failure.

Circulating MicroRNA Profiles Differ Between Qi-Stagnation and Qi-Deficiency in Coronary Heart Disease Patients with Blood Stasis Syndrome

Profiling of plasma miRNA in chronic heart failure patients

Exosomal miRNAs in patients with chronic heart failure and hyperuricemia and the underlying mechanisms

Diagnostic potential of a circulating miRNA model associated with therapeutic effect in heart failure

Expression profiles and potential functions of microRNAs in heart failure patients from the Uyghur population

Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy

Diagnostic and prognostic significance of miR-320a-3p in patients with chronic heart failure

Potential diagnostic value of circulating miRNAs in HFrEF and bioinformatics analysis

Identification and analysis of differential miRNA–mRNA interactions in coronary heart disease: an experimental screening approach

Identification and validation of circulating microRNAs as biomarkers for heart failure with preserved ejection fraction

Combination of PBMC Mir-19B-5p, Mir-221, Mir-25-5p and Hypertension Correlates with Increased Risk of Heart Failure in Coronary Heart Disease Patients

Circulating microRNAs as novel biomarkers for dilated cardiomyopathy.

Expression of Microrna-214 and Galectin-3 in Peripheral Blood of Patients with Chronic Heart Failure and Its Clinical Significance

Association Between Elevated Plasma Microrna-223 Content and Severity of Coronary Heart Disease

Diagnostic and prognostic value of microRNA423-5p in patients with heart failure

Abstract 13856: Circulating Microrna Differentiates HFpEF and HFrEF Patients

Circulating miRNA-302 family members as potential biomarkers for the diagnosis of acute heart failure.